Search research articles
Contact Us
Filters
Showing results (231-240 of 312) with videos related to
Page
of 32
Sort By:
Journal of Inherited Metabolic Disease
|
January 1, 1984
Pyruvate carboxylase deficiency
K Bartlett, H K Ghneim, J H Stirk, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 15, 1988
The characterisation of molecular forms of acetylcholinesterase in Hirschsprung's disease
J R Bonham, G Dale, D J Scott, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 16, 2003
The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants
Christina I Armpilia, Roger G Dale, Ian P Coles, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 26, 2001
The role of biologically effective dose (BED) in clinical oncology
B Jones, R G Dale, C Deehan, et al.
British Medical Journal (Clinical Research Ed.)
|
April 11, 1987
Fitness, unfitness, and phosphate
G Dale, J A Fleetwood, A Weddell, et al.
Bulletin De L'Academie Nationale De Medecine
|
January 1, 1991
[Principles and first results of the European program of breast cancer screening in the Bas-Rhin]
R Renaud, P Schaffer, B Gairard, et al.
The British Journal of Radiology
|
March 1, 2012
Fast neutron relative biological effects and implications for charged particle therapy
B Jones, T S A Underwood, A Carabe-Fernandez, et al.
Lancet (London, England)
|
February 17, 1979
Diagnostic value of rectal mucosal acetylcholinesterase levels in Hirschsprung's disease
G Dale, J R Bonham, P Lowdon, et al.
Surgery
|
March 1, 1977
The effect of surgical operation on venous plasma free amino acids
G Dale, G Young, A L Latner, et al.
Radiation Oncology (London, England)
|
October 21, 2018
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity
Christy Goldsmith, P Nicholas Plowman, Melanie M Green, et al.
Page
of 32
Search research articles
Search
Showing results (231-240 of 312) with videos related to
Sort By:
Page
of 32
Journal of Inherited Metabolic Disease
|
January 1, 1984
Pyruvate carboxylase deficiency
K Bartlett, H K Ghneim, J H Stirk, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry
|
February 15, 1988
The characterisation of molecular forms of acetylcholinesterase in Hirschsprung's disease
J R Bonham, G Dale, D J Scott, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 16, 2003
The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implants
Christina I Armpilia, Roger G Dale, Ian P Coles, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
May 26, 2001
The role of biologically effective dose (BED) in clinical oncology
B Jones, R G Dale, C Deehan, et al.
British Medical Journal (Clinical Research Ed.)
|
April 11, 1987
Fitness, unfitness, and phosphate
G Dale, J A Fleetwood, A Weddell, et al.
Bulletin De L'Academie Nationale De Medecine
|
January 1, 1991
[Principles and first results of the European program of breast cancer screening in the Bas-Rhin]
R Renaud, P Schaffer, B Gairard, et al.
The British Journal of Radiology
|
March 1, 2012
Fast neutron relative biological effects and implications for charged particle therapy
B Jones, T S A Underwood, A Carabe-Fernandez, et al.
Lancet (London, England)
|
February 17, 1979
Diagnostic value of rectal mucosal acetylcholinesterase levels in Hirschsprung's disease
G Dale, J R Bonham, P Lowdon, et al.
Surgery
|
March 1, 1977
The effect of surgical operation on venous plasma free amino acids
G Dale, G Young, A L Latner, et al.
Radiation Oncology (London, England)
|
October 21, 2018
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicity
Christy Goldsmith, P Nicholas Plowman, Melanie M Green, et al.
Page
of 32